Skip to content

AKTSAKTIS ONCOLOGY INC

CUSIP 01021M104 · common stock

2 tracked investors held AKTIS ONCOLOGY INC (AKTS) at the end of Q3 2026, worth $20.8M in total. The largest holder was Julian Baker, with 0.1% of its portfolio. 2 investors sold out this quarter, including RA Capital Management.

Holders · Q3 2026
2
New holders
0
Value held
$20.8M
Quarter-end price (est.)
$19.47

Investors holding AKTS · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.09%996,351$19.4MHOLD
Polen Capital Management
Polen Capital Management LLC
0.02%72,795$1.4MADD+14.6%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
RA Capital Management0.37%1,314,405$42.4MEXIT
George Soros0.04%100,000$3.2MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026202$20.8M$19.47
Q2 2026410$79.7M$32.23
Q1 2026330$46.5M$17.89